the market?
Immunomedics, Inc.
NASDAQ: IMMU
3.14
0.03
(0.96%)
| Today's Open | $3.13 |
|---|---|
| Previous Close | $3.11 |
| Daily Range | $3.10 - $3.17 |
| 52-Week Range | $2.11 - $3.76 |
| Market Cap | $259.7M |
| P/E Ratio | -19.44 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 429,403 |
| Average Daily Volume | 421,619 |
| Current FY EPS | -$0.38 |
How do you think IMMU
will perform against the market?
Top IMMU Bull/Bear Pitches
NeroSagetrade (< 20)
Submitted
October 13, 2007
This is my one...my ONE feel good story in my CAPS portfolio. I've followed Immunomedics for roughly six years and I've liked the direction management has taken the company in each successive year. Th … More
News & Commentary
Tackling Cancer: Non-Hodgkin Lymphoma's Biggest Current & Upcoming Players
Cancer research is big business, and it pays to know where research dollars are headed.In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure
Following successful in vitro studies, Danish researchers are on the fast track to human clinical trials.Why Merrimack Is Poised to Outperform
Market-trouncing returns could be written in this 5-Star.3 Stocks Near 52-Week Lows Worth Buying
Do these fallen angels deserve a second chance? You be the judge!Why Clovis Oncology Is Poised to Plunge
Market-lagging returns could be written in this 2-Star.Sector
Healthcare
Industry
Drugs
Immunomedics, Inc. (IMMU) Description
A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. Website: http://www.immunomedics.com/
More details for Immunomedics Jobs
Immunomedics reviews from employees
